CIBG-166a

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCIBG-166a
Drug Alias NameCIGB-166a
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionVascular endothelial growth factor receptor 1 antagonistsVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 2Vascular endothelial growth factor receptor 1
Therapy Area/IndicationsMacular DegenerationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCuba
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenter For Genetic Engineering And Biotechnology
Active IndicationsN/A
Inactive IndicationsMacular DegenerationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A